LISATA THERAPEUTICS, INC. Cash and Restricted Cash
LISATA THERAPEUTICS, INC. (LSTA) had Cash and Restricted Cash of $10.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.44M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.06M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.96M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $10.44M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $13.06M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $15.96M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $19.00M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $16.84M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $20.22M 10-Q · filed 2026-05-11 | |
| 2024-12-31 | $16.21M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $19.51M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $28.29M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $21.80M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $22.59M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $32.43M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $23.69M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $28.16M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $32.15M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $31.48M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $33.35M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $12.75M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $24.65M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $12.77M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $12.94M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $28.74M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $16.51M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $21.16M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $14.03M 10-K · filed 2022-03-22 | |
| 2018-12-31 | $10.30M 10-K · filed 2021-02-25 | |
| 2018-03-31 | $26.61M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $34.17M 10-K · filed 2020-03-05 | $34.17M 10-K · filed 2018-03-22 |
| 2017-09-30 | $20.08M 10-Q · filed 2017-11-09 | |
| 2017-03-31 | $8.92M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $7.08M 10-K · filed 2019-03-14 | $7.08M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $11.64M 10-Q · filed 2017-11-09 | |
| 2015-12-31 | $18.66M 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |